DNA-scaffolded biomaterials enable modular and tunable control of cell-based cancer immunotherapies.

DNA-scaffolded biomaterials enable modular and tunable control of cell-based cancer immunotherapies. . 2019 Mar 23; 587105.

2019
https://researcherprofiles.org/profile/79290276